| P2093 | author name string | Michael P Diamond | |
| | Hamid-Reza Kohan-Ghadr | |
| | D Randall Armant | |
| | Sascha Drewlo | |
| | Alan D Bolnick | |
| | Brian A Kilburn | |
| | Jay M Bolnick | |
| | Rani Fritz | |
| P2860 | cites work | A primate subfamily of galectins expressed at the maternal-fetal interface that promote immune cell death | Q24317162 |
| | Transcervical retrieval of fetal cells in the practice of modern medicine: a review of the current literature and future direction | Q24608555 |
| | Adverse pregnancy outcome, the uteroplacental interface, and preventive strategies | Q28221238 |
| | Fetal cells in the uterine cervix: a source for early non-invasive prenatal diagnosis | Q30708361 |
| | Serum screening with Down's syndrome markers to predict pre-eclampsia and small for gestational age: systematic review and meta-analysis | Q33357689 |
| | Retrieval of trophoblast cells from the cervical canal for prediction of abnormal pregnancy: a pilot study | Q33460899 |
| | The pre-eclampsia community guideline (PRECOG): how to screen for and detect onset of pre-eclampsia in the community | Q33930523 |
| | Placental debris, oxidative stress and pre-eclampsia | Q34032003 |
| | Severe limb reduction defects after uterine lavage at 7-8 weeks' gestation. | Q50975791 |
| | Re: Uterine artery Doppler and sFlt-1/PlGF ratio: prognostic value in early-onset pre-eclampsia. P. I. Gómez-Arriaga, I. Herraiz, E. A. López-Jiménez, D. Escribano, B. Denk and A. Galindo. Ultrasound Obstet Gynecol 2014; 43: 525-532. | Q54355702 |
| | [Value of second trimester maternal serum sFlt-1, PlGF and their ratio in the prediction of preeclampsia]. | Q54362939 |
| | Trophoblast retrieval and isolation from the cervix (TRIC) for noninvasive prenatal screening at 5 to 20 weeks of gestation | Q58803674 |
| | Use of the Y Chromosome in Prenatal Sex Determination | Q59074357 |
| | Elevated maternal serum alpha-fetoprotein levels and midtrimester placental abnormalities in relation to subsequent adverse pregnancy outcomes | Q67544297 |
| | The role of the spiral arteries in the pathogenesis of preeclampsia | Q69446253 |
| | Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational age infants | Q69685000 |
| | Comparison of cytobrush and cotton swab for Papanicolaou smears in pregnancy | Q70591219 |
| | Detection of trophoblast cells in transcervical samples collected by lavage or cytobrush | Q71899849 |
| | Evaluation of the endocervical Cytobrush and Cervex-Brush in pregnant women | Q72199897 |
| | Placental apoptosis in preeclampsia | Q74047219 |
| | Increased apoptosis in the syncytiotrophoblast in human term placentas complicated by either preeclampsia or intrauterine growth retardation | Q77543305 |
| | Maternal serum placental growth factor (PlGF) isoforms 1 and 2 at 11-13 weeks' gestation in normal and pathological pregnancies | Q87155186 |
| | Placental protein 13 (PP13): a new biological target shifting individualized risk assessment to personalized drug design combating pre-eclampsia | Q34328411 |
| | Evolutionary origins of the placental expression of chromosome 19 cluster galectins and their complex dysregulation in preeclampsia | Q34372600 |
| | Latest advances in understanding preeclampsia | Q34425288 |
| | Invasive prenatal diagnostic techniques. | Q34501680 |
| | Noninvasive detection of trophoblast protein signatures linked to early pregnancy loss using trophoblast retrieval and isolation from the cervix (TRIC). | Q35655676 |
| | Differential expression of vascular endothelial growth factor (VEGF), endocrine gland derived-VEGF, and VEGF receptors in human placentas from normal and preeclamptic pregnancies | Q35764454 |
| | Preeclampsia is associated with widespread apoptosis of placental cytotrophoblasts within the uterine wall | Q35787199 |
| | The role of uterine artery Doppler in predicting adverse pregnancy outcome | Q35795797 |
| | Placental oxidative stress: from miscarriage to preeclampsia | Q35879133 |
| | Clinical inquiries. Should a nylon brush be used for Pap smears from pregnant women? | Q36113072 |
| | The utility of uterine artery Doppler velocimetry in prediction of preeclampsia in a low-risk population | Q36253829 |
| | Preeclampsia and angiogenic imbalance | Q36971766 |
| | Potential markers of preeclampsia--a review | Q37278804 |
| | Preeclampsia is associated with failure of human cytotrophoblasts to mimic a vascular adhesion phenotype. One cause of defective endovascular invasion in this syndrome? | Q37366512 |
| | First-trimester maternal serum PP13 in the risk assessment for preeclampsia. | Q37444801 |
| | The Human Placenta Project: placental structure, development, and function in real time | Q37722793 |
| | The promise of angiogenic markers for the early diagnosis and prediction of preeclampsia | Q37995181 |
| | Novel biomarkers for predicting intrauterine growth restriction: a systematic review and meta-analysis | Q38080626 |
| | Abnormal blood biomarkers in early pregnancy are associated with preeclampsia: a meta-analysis | Q38259145 |
| | Evaluation of trophoblast HLA-G antigen with a specific monoclonal antibody | Q40885662 |
| | The efficacy and safety of the cytobrush during pregnancy | Q41888855 |
| | Gene expression in chorionic villous samples at 11 weeks' gestation from women destined to develop preeclampsia. | Q44076540 |
| | Can maternal serum placental growth factor estimation in early second trimester predict the occurrence of early onset preeclampsia and/or early onset intrauterine growth restriction? A prospective cohort study | Q45230594 |
| | The association between maternal serum alpha-fetoprotein and preterm birth, small for gestational age infants, preeclampsia, and placental complications. | Q45973795 |
| | Maternal serum soluble endoglin at 30-33 weeks in the prediction of preeclampsia. | Q46505791 |
| | Circulating angiogenic factors and the risk of preeclampsia | Q47217679 |
| | Prediction of obstetrical risk using maternal serum markers and clinical risk factors. | Q47825018 |
| | Clustering of maternal-fetal clinical conditions and outcomes and placental lesions | Q47833595 |
| | Early pregnancy levels of pregnancy-associated plasma protein a and the risk of intrauterine growth restriction, premature birth, preeclampsia, and stillbirth | Q47864591 |
| | Endothelial dysfunction in preeclampsia | Q47879591 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | biomarker | Q864574 |
| | perinatal disease | Q18968218 |
| P304 | page(s) | 32382 | |
| P577 | publication date | 2016-09-23 | |
| P1433 | published in | Scientific Reports | Q2261792 |
| P1476 | title | Altered Biomarkers in Trophoblast Cells Obtained Noninvasively Prior to Clinical Manifestation of Perinatal Disease | |
| P478 | volume | 6 | |